Manipulation of Avidity to Improve Effectiveness of Adoptively Transferred CD8+ T Cells for Melanoma Immunotherapy in Human MHC Class I-Transgenic Mice1

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Immunology

• Publication date

  2001-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.167.10.5824PMID 11698456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct identification of tumor-associated peptide antigens

  2004cited by this paper
• Functional avidity maturation of CD8+ T cells without selection of higher affinity TCR

  2001cited by this paper
• Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining.

  2001cited by this paper
• Immune Responses to the HLA-A*0201-Restricted Epitopes of Tyrosinase and Glycoprotein 100 Enable Control of Melanoma Outgrowth in HLA-A*0201-Transgenic Mice1

  2001cited by this paper
• The amplification of TCR signaling by dynamic membrane microdomains.

  2001cited by this paper
• Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen.

  2001cited by this paper
• Cutting Edge: Lipid Raft Integrity Affects the Efficiency of MHC Class I Tetramer Binding and Cell Surface TCR Arrangement on CD8+ T Cells1

  2001cited by this paper
• Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex

  2001cited by this paper
• Critical Role for Cd8 in T Cell Receptor Binding and Activation by Peptide/Major Histocompatibility Complex Multimers

  2000cited by this paper
• The Density of Peptides Displayed by Dendritic Cells Affects Immune Responses to Human Tyrosinase and gp100 in HLA-A2 Transgenic Mice1

  2000cited by this paper
• Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma.

  2000cited by this paper
• Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen

  2000cited by this paper
• Role of CD8β Domains in CD8 Coreceptor Function

  2000cited by this paper
• Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas1

  2000cited by this paper
• Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling.

  2000cited by this paper
• Role of CD8beta domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus.

  2000cited by this paper
• Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.

  1999cited by this paper
• Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.

  1999cited by this paper
• A kinetic basis for T cell receptor repertoire selection during an immune response.

  1999cited by this paper
• Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.

  1999cited by this paper
• Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice.

  1999cited by this paper
• Human tumor antigens for cancer vaccine development

  1999cited by this paper
• Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.

  1999cited by this paper
• T lymphocyte costimulation mediated by reorganization of membrane microdomains.

  1999cited by this paper
• Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands.

  1999influential reference
• High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy.

  1999cited by this paper
• T Cell Affinity Maturation by Selective Expansion during Infection

  1999cited by this paper
• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

  1998cited by this paper
• gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand

  1998cited by this paper
• Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells.

  1998cited by this paper
• Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.

  1998cited by this paper
• Peptide antagonism and T cell receptor interactions with peptide-MHC complexes.

  1998cited by this paper
• Prospects for adoptive T cell therapy.

  1997cited by this paper
• Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma

  1997cited by this paper
• Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.

  1996cited by this paper
• Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.

  1996cited by this paper
• Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

  1996cited by this paper
• Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.

  1995cited by this paper
• Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness.

  1994influential reference
• The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

  1994cited by this paper
• Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

  1994cited by this paper
• Identification of human cancers deficient in antigen processing

  1993cited by this paper
• Tumor Escape from Immune Response by Variation in HLA Expression and Other Mechanisms

  1993cited by this paper
• Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides.

  1993cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.

  1991cited by this paper
• Heteroclitic antibodies: differences in fine specificities between monoclonal antibodies directed against dinitrophenyl and trinitrophenyl haptens.

  1988cited by this paper
• Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

  1988cited by this paper
• SPECIFICITY OF THE IMMUNE RESPONSE TO THE 2, 4-DINITROPHENYL AND 2, 4, 6-TRINITROPHENYL GROUPS

  1969cited by this paper

• Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity

  2023cites this paper
• Strategies and rules for tuning TCR-derived therapy

  2023cites this paper
• Global koff‐rates of polyclonal T‐cell populations merge subclonal avidities and predict functionality

  2022cites this paper
• A minimal model of T cell avidity may identify subtherapeutic vaccine schedules

  2020cites this paper
• Immature dendritic cells promote high-avidity tuning of vaccine T cell response

  2020cites this paper
• Mature Dendritic Cells May Promote High-Avidity Tuning of Vaccine T Cell Responses

  2020cites this paper
• Low Avidity T Cells Do Not Hinder High Avidity T Cell Responses Against Melanoma

  2019cites this paper
• Impact of TCR-ligand avidity for viral and tumor antigens on human CD8 T cell potency and long-term persistence

  2019influential citation
• Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells.

  2019cites this paper
• HIV T-Cell Vaccines.

  2018cites this paper
• A humanized TCR retaining authentic specificity and affinity conferred potent anti‐tumour cytotoxicity

  2018cites this paper
• Assessing T Cell Receptor Affinity and Avidity Against Tumor Antigens

  2018cites this paper
• High-throughput determination of the antigen specificities of T cell receptors in single cells

  2018cites this paper
• TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency.

  2017cites this paper
• HLA y expresión de receptores NK en pacientes con melanoma

  2016cites this paper
• Peptide–MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development

  2015cites this paper
• High-Avidity Tumor Antigen-Specific CD 8 T Cell Help Selectively Enhances + CD 4 Bronte and

  2015cites this paper
• CD4+ T Cell Help Selectively Enhances High-Avidity Tumor Antigen-Specific CD8+ T Cells

  2015cites this paper
• Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens

  2015cites this paper
• Peptide Dose and/or Structure in Vaccines as a Determinant of T Cell Responses

  2014cites this paper
• Structural and Functional Correlates of Enhanced Antiviral Immunity Generated by Heteroclitic CD8 T Cell Epitopes

  2014cites this paper
• Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer

  2014cites this paper
• T Cell Avidity and Tumor Immunity: Problems and Solutions

  2014cites this paper
• T cell responses to S-glutathionylated And heteroclitic viral epitopes and CCl2-mediated immune dysregulation in mice infected with a neurotropic coronavirus

  2014cites this paper
• This information is current as HLA-A*0201-Transgenic Mice Control of Melanoma Outgrowth in Tyrosinase and Glycoprotein 100 Enable HLA-A*0201-Restricted Epitopes of Immune Responses to the

  2013cites this paper
• High-avidity T cells are preferentially tolerized in the tumor microenvironment.

  2013cites this paper
• In vivo Modulation of Avidity in Highly Sensitive CD8+ Effector T Cells Following Viral Infection

  2013cites this paper
• by CD8-Independent Tetramer Staining High Avidity Antigen-Specific CTL Identified

  2013cites this paper
• in Human T Cells β α Favors Specific Pairing of Introduced TCR Interface β α Molecular Design of the C

  2013cites this paper
• Ipilimumab in prostate cancer

  2013cites this paper
• Changes in Functional but Not Structural Avidity during Differentiation of CD8+ Effector Cells In Vivo after Virus Infection

  2012cites this paper
• Functional differences between low- and high-affinity CD8+ T cells in the tumor environment

  2012cites this paper
• Effector Cells In Vivo after Virus Infection + Avidity during Differentiation of CD8 Changes in Functional but Not Structural

  2012cites this paper
• Increased sensitivity to antigen in high avidity CD8+ T cells results from augmented membrane proximal T‐cell receptor signal transduction

  2011cites this paper
• Tetramer Staining Identified by CD8-Independent High Avidity Antigen-Specific CTL

  2010cites this paper
• CD8+ T cell recognition of polymorphic wild-type sequence p5365–73 peptides in squamous cell carcinoma of the head and neck

  2010cites this paper
• Coxsackievirus B4 in southern Taiwan: molecular epidemiology.

  2009cites this paper
• Stimulation of Enhanced CD8 T Cell Responses Following Immunization with a Hyper-Antigen Secreting Intracytosolic Bacterial Pathogen1

  2008cites this paper
• Bacterial Pathogen Hyper-Antigen Secreting Intracytosolic Responses Following Immunization with a Stimulation of Enhanced CD 8 T Cell

  2008cites this paper
• Molecular Design of the Cαβ Interface Favors Specific Pairing of Introduced TCRαβ in Human T Cells1

  2008cites this paper
• Strategies and challenges in eliciting immunity to melanoma

  2008cites this paper
• A Multipeptide Vaccine is Safe and Elicits T-cell Responses in Participants With Advanced Stage Ovarian Cancer

  2008cites this paper
• Cytotoxic T-Lymphocyte Responses to Human Papillomavirus Type 16 E5 and E7 Proteins and HLA-A*0201-Restricted T-Cell Peptides in Cervical Cancer Patients

  2007cites this paper
• Mobilizing the low-avidity T cell repertoire to kill tumors.

  2007cites this paper
• Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs.

  2007cites this paper
• Cytotoxic T-Lymphocyte Responses to Human Papillomavirus Type 16 E 5 and E 7 Proteins and HLA-A * 0201-Restricted T-Cell Peptides in Cervical Cancer Patients

  2007cites this paper
• Roadmap to a Better Therapeutic Tumor Vaccine

  2006cites this paper
• Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.

  2006cites this paper
• Immunity to melanoma antigens: from self-tolerance to immunotherapy.

  2006cites this paper
• Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes1

  2006cites this paper
• Lymphocytes Mononuclear Cells and Tumor-Infiltrating Reactivity to Nonreactive Peripheral Blood Confers Both High Avidity and Tumor Gene Transfer of Tumor-Reactive TCR

  2006cites this paper
• Limited Infiltration of Exogenous Dendritic Cells and Naive T Cells Restricts Immune Responses in Peripheral Lymph Nodes1

  2006cites this paper
• This information is current as Responses in Peripheral Lymph Nodes Cells and Naive T Cells Restricts Immune Limited Infiltration of Exogenous Dendritic

  2006cites this paper
• Immunization of Volunteers with Salmonella enterica Serovar Typhi Strain Ty21a Elicits the Oligoclonal Expansion of CD8+ T Cells with Predominant Vβ Repertoires

  2005cites this paper
• The Fate of Low Affinity Tumor-Specific CD8+ T Cells in Tumor-Bearing Mice1

  2005cites this paper
• Induction of Higher-Avidity Human CTLs by Vector-Mediated Enhanced Costimulation of Antigen-Presenting Cells

  2005cites this paper
• Antitumor Reactivity Peptide-MHC Levels Elicits Strong Tumor-Infiltrating T Lymphocytes to In Situ Sensory Adaptation

  2005cites this paper
• In Situ Sensory Adaptation of Tumor-Infiltrating T Lymphocytes to Peptide-MHC Levels Elicits Strong Antitumor Reactivity1

  2005cites this paper
• Multiple Costimulatory Modalities Enhance CTL Avidity

  2005cites this paper
• A HER-2/neu peptide admixed with PLA microspheres induces a Th1-biased immune response in mice.

  2005cites this paper
• This information is current as CTL Avidity Multiple Costimulatory Modalities Enhance

  2005cites this paper
• Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA‐A2/Mage3 complex density using a high‐affinity TCR like monoclonal antibody

  2005cites this paper
• High-avidity CD8+ T cells

  2005cites this paper
• Chapter 40 – Cancer – Solid Tumors

  2005cites this paper
• T Cells in Tumor-Bearing Mice + CD8The Fate of Low Affinity Tumor-Specific

  2005cites this paper
• Multiple Costimulatory Modalities Enhance

  2005cites this paper
• Immunization of Volunteers with Salmonella enterica Serovar Typhi Strain Ty21a Elicits the Oligoclonal Expansion of CD8 (cid:1) T Cells with Predominant V (cid:2) Repertoires

  2005cites this paper
• How does the immune system attack cancer

  2004cites this paper
• Response of established human breast tumors to vaccination with mammaglobin-A cDNA.

  2004cites this paper
• Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes

  2004cites this paper
• Poor immunogenicity of a self/tumor antigen derives from peptide-MHC-I instability and is independent of tolerance.

  2004cites this paper
• Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword?

  2004cites this paper
• Immunological Monitoring of Patients with Melanoma After Peptide Vaccination Using Soluble Peptide/HLA-A2 Dimer Complexes

  2004cites this paper
• Immunotherapy of surgical malignancies.

  2004cites this paper
• Partial tyrosinase‐specific self tolerance by HLA‐A*0201‐restricted cytotoxic T lymphocytes in mice and man

  2004cites this paper
• Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

  2003cites this paper
• Does the immune system see tumors as foreign or self?

  2003cites this paper
• Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cells.

  2003cites this paper
• Altered Antiviral T Cell Hierarchy Cells During Negative Selection Results in an T + Preferential Escape of Subdominant CD 8

  2003cites this paper
• Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.

  2003cites this paper
• Molecular mechanisms and biological significance of CTL avidity.

  2003cites this paper
• α3 Domain Mutants of Peptide/MHC Class I Multimers Allow the Selective Isolation of High Avidity Tumor-Reactive CD8 T Cells1

  2003cites this paper
• CD 8-Independent Tetramer Staining High Avidity Antigen-Specific CTL Identified Vincenzo Cerundolo

  2003cites this paper
• Antigen Density Presented By Dendritic Cells In Vivo Differentially Affects the Number and Avidity of Primary, Memory, and Recall CD8+ T Cells 1

  2003cites this paper
• High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining 1

  2003cites this paper
• Route of Immunization with Peptide-pulsed Dendritic Cells Controls the Distribution of Memory and Effector T Cells in Lymphoid Tissues and Determines the Pattern of Regional Tumor Control

  2003cites this paper
• Preferential Escape of Subdominant CD8+ T Cells During Negative Selection Results in an Altered Antiviral T Cell Hierarchy 1

  2003cites this paper
• Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes

  2003cites this paper
• Structural and kinetic basis for low affinity cross‐reactivity in T cell allorecognition

  2003cites this paper
• Antigens derived from melanocyte differentiation proteins: self‐tolerance, autoimmunity, and use for cancer immunotherapy

  2002cites this paper
• Cytotoxic T-Lymphocyte Escape Monitoring in Simian Immunodeficiency Virus Vaccine Challenge Studies

  2002cites this paper
• Current status of adoptive immunotherapy of malignancies

  2002cites this paper
• The T-cell response in patients with cancer.

  2002cites this paper
• Identification of HLA‐A3‐restricted CD8+ T cell epitopes derived from mammaglobin‐A, a tumor‐associated antigen of human breast cancer

  2002cites this paper
• Vaccination against the HER-2/neu oncogenic protein.

  2002cites this paper
• Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution

  2002cites this paper
• Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire.

  2002cites this paper
• Primary immune deficiency disease Linking V(D)J recombination and DNA repair: role of artemis in severe combined immune deficiency with abnormal radiosensitivity Related review: V(D)J recombination and DNA repair: lessons from human immune deficiencies

  2002cites this paper
• Immune Responses to the HLA-A*0201-Restricted Epitopes of Tyrosinase and Glycoprotein 100 Enable Control of Melanoma Outgrowth in HLA-A*0201-Transgenic Mice1

  2001cites this paper